PDA's Artificial Intelligence workshop puts AI experts and practitioners — alongside regulators and standards bodies — in the same room to work through the complete AI lifecycle in pharmaceutical manufacturing. The 2026 edition runs in Berlin, Germany.
Dates and format
- Dates: 11-12 November 2026
- Location: Berlin, Germany (exact venue unconfirmed from a primary source)
- Organizer: Parenteral Drug Association (PDA)
- Opening session (11 Nov): “Boundaries of Regulations” panel with regulatory and industry panelists
What it covers
As AI frameworks such as the EU's draft GMP Annex 22, FDA's AI/ML initiatives, Swissmedic guidance and USP activities continue to evolve, manufacturers need practical strategies for implementing AI inside GxP environments. PDA's workshop is built as a working session rather than a lecture series: AI experts, practitioners, regulators and standards leaders co-develop guidance intended to support scalable, compliant and trustworthy AI adoption across global regulatory frameworks.
Who should attend
Quality and manufacturing leaders evaluating AI tools for GMP operations, regulatory affairs professionals tracking how FDA, EMA and Swissmedic are each approaching AI oversight, and validation specialists who will own the computerized-systems case for whatever a site deploys. The format rewards attendees who can engage directly in working sessions rather than observe from the back of a plenary.
Looking further ahead? WCBP 2027 runs in January, and the full events directory lists everything we have verified.
Frequently asked questions
When and where is the PDA Artificial Intelligence workshop?
11-12 November 2026 in Berlin, Germany. Third-party listings name the Meliá Berlin as the venue, but this was not confirmed directly from PDA's own page in sources reviewed for this listing, so confirm the exact location with PDA before booking travel.
Who organizes it?
The Parenteral Drug Association (PDA).
What does the workshop cover?
The full AI lifecycle in pharmaceutical manufacturing — regulatory frameworks including EU GMP Annex 22, FDA AI/ML initiatives, Swissmedic guidance and USP activities — through collaborative sessions where regulators, standards bodies and industry co-develop practical guidance for AI adoption in GxP environments.
Is this workshop in person or virtual?
PDA's page was not directly reachable to confirm the format. Based on the workshop's described collaborative, side-by-side sessions and poster session, it reads as an in-person event, but this is inferred rather than confirmed — check PDA's own event page before planning travel.
Sources & further reading
- Parenteral Drug Association. PDA Artificial Intelligence — A Revolution in Pharma Manufacturing Workshop 2026. pda.org
- Parenteral Drug Association. Event agenda — PDA Artificial Intelligence Workshop 2026. pda.org
Event details are published by the organizer and can change. This listing was corroborated via web search rather than a direct fetch of the organizer's page (network egress was blocked this session); confirm dates, venue and format with PDA before making plans. Last verified 1 October 2026.
